Vitamin D Status and Asthma Control, Pulmonary Function, and Oxidative Stress in Adults With Bronchial Asthma

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSinai University

About this trial

Asthma is a chronic inflammatory airway disease associated with variable airflow limitation and persistent respiratory symptoms. Vitamin D has been proposed as a potential biomarker related to immune regulation, asthma control, pulmonary function, and oxidative stress balance.

This prospective cross-sectional observational study aims to investigate the association between serum 25-hydroxyvitamin D \[25(OH)D\] concentrations, asthma control, pulmonary function parameters, and erythrocyte oxidative stress biomarkers among Egyptian adults with bronchial asthma.

A total of 200 adult asthma patients will be recruited from Abbassia Chest Hospital, Cairo, Egypt. Participants will undergo clinical assessment, Asthma Control Test (ACT), post-bronchodilator spirometry, serum vitamin D measurement, and oxidative stress biomarker assessment including malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), and reduced glutathione (GSH).

Participants will be categorized according to serum 25(OH)D concentrations into vitamin D deficient, insufficient, and sufficient groups.

No intervention or treatment assignment will be performed.

5\. Detailed Description

Eligibility criteria

Qualifiers

Age ≥ 18 years.

Confirmed diagnosis of bronchial asthma.

Clinically stable at the time of assessment.

Availability of spirometry results.

Disqualifiers

Other chronic pulmonary diseases.

Active respiratory infection.

Malignancy.

Significant renal or hepatic disease.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

134 Participants
are grouped into 3 trial groups

Locations

This trial has no locations

Sponsors and collaborators